lues are stated in figure legends. Results Stable Transfection of HESC with Pax4 We first examined the expression of Pax4 in HESC and their differentiated derivatives. Neither mRNA nor protein were detected for Pax4 in undifferentiated H7 HESC, by RT-PCR or Western blotting respectively. To induce in vitro differentiation of HESC, we applied the suspension method used for EB formation, which resulted in an increased, but low level expression of Pax4 mRNA and protein. We isolated the coding sequence for human Pax4 by PCR from differentiated H7 EBs and inserted it into the pCAG vector upstream of an IRES linking it to the puromycin resistance gene. Previously, we found that this vector can be used to derive stable transfectants of HESC without subsequent gene silencing. Following transfection and selection with puromycin we isolated several independent clones of H7 HESC, three of which were used in subsequent studies. All the undifferentiated H7.Px4 transfectants expressed the Pax4 transgene, detected by RT-PCR for the CDS region, but not the endogenous gene detected by RT-PCR for the 59UTR, which was absent from the transgene. During differentiation, the expression of the endogenous Pax4 mRNA was substantially increased in the H7.Px4 EBs, and its induction occurred earlier than in the EBs of untransfected cells. Most likely, this reflects a positive transcriptional 10609556 feedback loop Beta-Cells from Human ES Cells since the Pax4 promoter contains several binding sites for Pax4 itself. Pax4 protein was also strongly expressed in the transfected cells compared to the untransfected cells. Before induction of differentiation, the transfected cells retained an undifferentiated phenotype despite their expression of Pax4. They expressed Oct4 similarly to the untransfected cells and retained the morphology and surface antigen expression markers and TRA-1-60) of undifferentiated HESC . Upregulation of b-cell Transcripts in H7.Px4 EBs during Differentiation To determine the behaviour of H7.Px4 cells during their growth as EBs, we next examined the expression of a panel of cell-specific genes and proteins during EB differentiation. In untransfected and H7.Px4 cells, the expression of Oct4 was downregulated during EB growth over a 16 day period, though Beta-Cells from Human ES Cells KATP channel genes, KCNJ11 and ABCC8. However, there were marked differences in the expression of several genes associated with the b-cell lineage. Pdx1, Islet-1, Ins, AT 7867 site SLC2A2, Gck and PC1/3 were all expressed more strongly, with an earlier onset in the EBs from the H7.Px4 cells compared to the EBs from the untransfected cells. By itself, induction of Ins expression is suggestive but limited as a marker of `true’ b-cell differentiation. However, the expression of additional markers characteristic of functionally competent cells such as SLC2A2, Gck, Pdx1 and PC1/3, provides further support for the 16103101 appearance of bcells in H7.Px4 EBs. To confirm these results we 
also used quantitative PCR to examine the expression of Ins and Pdx1 in EBs from H7.Px4 clones. In each case, the EBs from the H7.Px4 clones showed enhanced expression of both Ins and Pdx1 compared to the untransfected cells, consistent with the expression of Pax4 promoting differentiation towards the b-cell lineage. Similar results were also obtained for Gck, Isl1 and SLC2A2. We also noted a significant influence of Pax4 expression on somatostatin and glucagon gene transcripts. Taken together, these gene expression patte
